Metraipolis › archive › dc_a5bcb5e263c2

What are RECIST 1.1 progressions made of? Variability in double-read oncology trials — Europe PMC PMID:41663830

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41663830
DOI
10.1007/s00330-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-06T00:00:48.972Z
SHA-256 of the archived text
055942fb45cf995ad3a62ee6fd3586b123bb6d030b62de2bed99e9994f1e0cce
Stable URL of this page
https://metraipolis.com/documento/dc_a5bcb5e263c2

How to cite

What are RECIST 1.1 progressions made of? Variability in double-read oncology trials — Europe PMC PMID:41663830 — Europe PMC (en), https://europepmc.org/article/MED/41663830 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5bcb5e263c2 (Metraipolis archive dc_a5bcb5e263c2, sha256 055942fb45cf995ad3a62ee6fd3586b123bb6d030b62de2bed99e9994f1e0cce)
BibTeX
@misc{dca5bcb5e263c2,
  title = {What are RECIST 1.1 progressions made of? Variability in double-read oncology trials — Europe PMC PMID:41663830},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41663830},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5bcb5e263c2; sha256 055942fb45cf995ad3a62ee6fd3586b123bb6d030b62de2bed99e9994f1e0cce},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41663830. Agents can read the archived copy with the MCP tool read_document.